GlassScriptPhysician profile
Gregory B Dodell
NPI 1053622449
$33,711.93
in general payments reported to CMS, 2019-2025
68 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,205 · 2020: $4,499 · 2021: $3,940 · 2022: $3,034 · 2023: $3,561 · 2024: $3,142 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $7,910 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,845.55 |
| Consulting Fee | $7,910.00 |
| Travel and Lodging | $278.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $10,212.36 | 2019-2025 | |
| Abbvie INC. | $5,951.17 | 2019-2025 | Synthroid, Ubrelvy, Linzess |
| Lilly USA, LLC | $2,040.81 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,828.70 | 2019-2025 | Lokelma, Farxiga, Breztri |
| Novo Nordisk INC | $1,596.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $952.27 | 2019-2025 | Evenity, Prolia, Repatha |
| Mannkind Corporation | $830.15 | 2019-2025 | Afrezza |
| Beta Bionics, INC. | $765.60 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Bayer Healthcare Pharmaceuticals INC. | $625.90 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $482.60 | 2019-2025 | Jardiance |
| Dexcom, INC. | $460.63 | 2019-2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $416.27 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Ibsa Pharma INC. | $379.58 | 2019-2024 | Tirosint, Licart, Tirosint |
| Intuity Medical INC | $365.09 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Pfizer INC. | $343.96 | 2023-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $321.57 | 2022-2025 | Rexulti |
| Radius Health, INC. | $281.40 | 2019-2025 | Tymlos, Binosto |
| Ascendis Pharma Endocrinology INC | $278.55 | 2023-2025 | Yorvipath |
| Abbott Laboratories | $253.28 | 2019-2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $250.82 | 2023-2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $240.25 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Amarin Pharma, INC. | $238.93 | 2019-2022 | |
| Astellas Pharma US INC | $236.03 | 2023-2025 | Veozah |
| Insulet Corporation | $233.37 | 2019-2025 | Omnipod |
| Merck Sharp & Dohme LLC | $224.12 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $207.93 | 2022-2024 | Quviviq |
| Corcept Therapeutics | $207.59 | 2022-2025 | Korlym |
| Glaxosmithkline, LLC. | $197.06 | 2019-2023 | Boostrix, Shingrix |
| Amneal Pharmaceuticals LLC | $182.85 | 2020-2025 | Unithroid |
| Ascensia Diabetes Care US INC. | $180.43 | 2021-2025 | |
| Shire North American Group INC | $171.91 | 2019 | |
| Lifescan, INC. | $170.53 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $160.85 | 2021-2025 | Strensiq |
| Kyowa Kirin, INC. | $148.68 | 2022-2025 | Crysvita |
| Acella Pharmaceuticals, LLC | $130.45 | 2023-2025 | NP Thyroid 60 |
| Valeritas, INC. | $117.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $114.90 | 2024-2025 | |
| Intra-Sana Laboratories | $113.09 | 2023-2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Biohaven Pharmaceutical Holding Company LTD. | $109.27 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $107.60 | 2019-2021 | |
| Medtronic, INC. | $107.28 | 2021-2024 | Minimed 780g |
| Aytu Biopharma, INC. | $106.69 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $101.29 | 2024-2025 | Tlando |
| Esperion Therapeutics, INC. | $95.13 | 2021 | |
| Cequr Corporation | $94.58 | 2022-2025 | Cequr Simplicity |
| Zealand Pharma US, INC. | $89.36 | 2020-2021 | |
| Eisai INC. | $81.84 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $81.69 | 2022-2025 | Isturisa |
| Horizon Therapeutics Plc | $78.38 | 2022-2023 | Tepezza |
| Biohaven Pharmaceuticals, INC. | $75.63 | 2021 | |
| Hologic Sales and Service, LLC | $65.83 | 2019 | |
| Medtronic Minimed, INC. | $64.36 | 2020 | |
| Neurocrine Biosciences, INC. | $56.53 | 2025 | |
| Vistapharm, INC. | $55.94 | 2021 | |
| Halozyme INC | $54.93 | 2023 | |
| Madrigal Pharmaceuticals | $52.22 | 2025 | Rezdiffra |
| Janssen Pharmaceuticals, INC | $44.39 | 2019 | |
| Acerus Pharmaceuticals Corporation | $44.20 | 2021-2022 | |
| Vivus LLC | $43.91 | 2019 | |
| Boston Scientific Corporation | $32.49 | 2023 | |
| Tandem Diabetes Care, INC. | $25.24 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ultragenyx Pharmaceutical INC. | $24.95 | 2020 | |
| Clarus Therapeutics INC. | $21.97 | 2021 | |
| Avion Pharmaceuticals | $20.69 | 2024 | NP Thyroid 60 |
| Tolmar, INC. | $19.83 | 2024 | |
| Eusa Pharma (US) LLC | $19.60 | 2022 | |
| Currax Pharmaceuticals LLC | $15.86 | 2024 | Contrave |
| Senseonics, Incorporated | $6.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dodell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.